83_FR_10911 83 FR 10862 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Transfer of a Premarket Notification

83 FR 10862 - Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Transfer of a Premarket Notification

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration

Federal Register Volume 83, Issue 49 (March 13, 2018)

Page Range10862-10863
FR Document2018-04995

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Federal Register, Volume 83 Issue 49 (Tuesday, March 13, 2018)
[Federal Register Volume 83, Number 49 (Tuesday, March 13, 2018)]
[Notices]
[Pages 10862-10863]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-04995]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2014-D-1837]


Agency Information Collection Activities; Submission for Office 
of Management and Budget Review; Comment Request; Transfer of a 
Premarket Notification

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
proposed collection of information has been submitted to the Office of 
Management and Budget (OMB) for review and clearance under the 
Paperwork Reduction Act of 1995.

DATES: Fax written comments on the collection of information by April 
12, 2018.

ADDRESSES: To ensure that comments on the information collection are 
received, OMB recommends that written comments be faxed to the Office 
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer, 
Fax: 202-395-7285, or emailed to [email protected]. All 
comments should be identified with the OMB control number 0910-New and 
title ``Transfer of a Premarket Notification.'' Also include the FDA 
docket number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Amber Sanford, Office of Operations, 
Food and Drug Administration, Three White Flint North, 10A-12M, 11601 
Landsdown St., North Bethesda, MD 20852, 301-796-8867, 
[email protected].

SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has 
submitted the following proposed collection of information to OMB for 
review and clearance.

Transfer of a Premarket Notification

OMB Control Number 0910-New

    The draft guidance ``Transfer of a Premarket Notification (510(k)) 
Clearance--Questions and Answers'' is intended to provide information 
on how to notify FDA of the transfer of a 510(k) clearance from one 
person to another, and the procedures FDA and industry should use to 
ensure public information in FDA's databases about the current 510(k) 
holder for a specific device(s) is accurate and up-to-date. The 
proposed information collection seeks to provide information to notify 
FDA of the transfer of a premarket notification (510(k)) clearance.
    The respondents to this collection of information are 510(k) 
holders and parties claiming to be 510(k) holders.
    In the Federal Register of December 22, 2014 (79 FR 76331), FDA 
published a 60-day notice requesting public comment on the proposed 
collection of information. While FDA received comments on the draft 
guidance document, none were related to the information collection.
    FDA estimates the burden of this collection of information as 
follows:

                                 Table 1--Estimated Annual Reporting Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of
            Activity                 Number of     responses per   Total annual   Average burden    Total hours
                                    respondents     respondent       responses     per response
----------------------------------------------------------------------------------------------------------------
Voluntary reporting of transfer            4,080               1           4,080            0.25           1,020
 of 510(k) clearance on FDA's
 Unified Registration and
 Listing System (FURLS) (outside
 of annual listing reporting
 requirement)...................
Submission of 510(k) transfer              2,033               1           2,033               4           8,132
 documentation when more than
 one party lists the same 510(k)
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............           9,152
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.

    FDA estimates that 78 percent of 510(k)s are listed outside of the 
annual registration cycle based on numbers in the FURLS database from 
fiscal year 2009 through fiscal year 2014. Fiscal year 2008 was left 
out of this cohort as it was the first year that registrants were 
required to report the 510(k) number on their listings and, therefore, 
an unusually high number of listings were created. An average of 5,231 
510(k)s have been listed each year since 2008.

[[Page 10863]]

Because listing outside of the annual requirement is voluntary, FDA 
estimates that annually 78 percent of 510(k)s will continue to be 
listed outside of the annual requirement. FDA estimates that 4,080 
510(k)s may be listed outside of the annual registration cycle. FDA 
estimates that it will take approximately 15 minutes for each listing, 
for a total reporting burden of 1,020 hours.
    FDA estimates it will have 2,033 instances of more than one party 
claiming to be a 510(k) holder for a specific device as part of annual 
registration and listing. FDA reached this estimate by identifying the 
number of unique 510(k) device listings entered in FURLS between fiscal 
years 2009 and 2014 that conflict with a listing already entered by 
another party (5,304), dividing that number by the number of years (6), 
and multiplying by the average number of parties claiming to be the 
510(k) holder when there is a conflict in the current FURLS database 
(2.3). The draft guidance identifies potential documentation a party 
could submit to FDA to establish the transfer of a 510(k) clearance. 
FDA estimates it will take a party approximately 4 hours to locate and 
submit information to establish the transfer of the 510(k) clearance, 
resulting in 8,132 burden hours for those 2,033 parties claiming to be 
510(k) holders. FDA reached this estimate based on its expectation of 
the amount of time it will take a party to locate the information, copy 
it, and submit a copy to FDA.
    The burden estimate does not include the maintenance of records 
used to document transferring a premarket notification (510(k)) 
clearance. Based on available information, FDA believes that the 
maintenance of these records is a usual and customary part of normal 
business activities. For example, in the ordinary course of business, 
supporting documents should be kept to verify asset information for 
calculating the annual depreciation or calculating gain or loss on sale 
of an asset on a businesses' tax return. Therefore, this recordkeeping 
requirement creates no additional paperwork burden.
    The draft guidance also refers to previously approved collections 
of information found in FDA regulations. The collections of information 
in 21 CFR part 807 (registration and listing) are approved under OMB 
control number 0910-0625; the collections of information in 21 CFR part 
807 subpart E (premarket notification submission) have been approved 
under OMB control number 0910-0120, and collections of information in 
42 CFR 493.17 have been approved under OMB control number 0910-0607.

    Dated: March 7, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-04995 Filed 3-12-18; 8:45 am]
 BILLING CODE 4164-01-P



                                             10862                                   Federal Register / Vol. 83, No. 49 / Tuesday, March 13, 2018 / Notices

                                             4. Fox, S. and L. Rainie (2002). ‘‘Vital                                         Investigating an Alternative Approach                                 title ‘‘Transfer of a Premarket
                                                  Decisions: How internet Users Decide                                        for Presenting Risk Information in                                    Notification.’’ Also include the FDA
                                                  What Information to Trust When They or                                      Prescription Drug Television                                          docket number found in brackets in the
                                                  Their Loved Ones Are Sick. Pew internet                                     Advertisements.’’ Research in Social &
                                                  & American Life Project.’’ Available at
                                                                                                                                                                                                    heading of this document.
                                                                                                                              Administrative Pharmacy. doi: 10.1016/
                                                  http://www.pewinternet.org/2002/05/22/                                      j.sapharm.2017.07.015.                                                FOR FURTHER INFORMATION CONTACT:
                                                  main-report-the-search-for-online-                                                                                                                Amber Sanford, Office of Operations,
                                                                                                                         Dated: March 7, 2018.
                                                  medical-help/.                                                                                                                                    Food and Drug Administration, Three
                                             5. DeLorme, D.E., J. Huh, and L.N. Reid                                   Leslie Kux,
                                                                                                                                                                                                    White Flint North, 10A–12M, 11601
                                                  (2011). ‘‘Source Selection in Prescription                           Associate Commissioner for Policy.
                                                  Drug Information Seeking and                                                                                                                      Landsdown St., North Bethesda, MD
                                                                                                                       [FR Doc. 2018–04996 Filed 3–12–18; 8:45 am]
                                                  Influencing Factors: Applying the                                                                                                                 20852, 301–796–8867, PRAStaff@
                                                                                                                       BILLING CODE 4164–01–P                                                       fda.hhs.gov.
                                                  Comprehensive Model of Information
                                                  Seeking in an American Context.’’
                                                  Journal of Health Communication, 16:
                                                                                                                                                                                                    SUPPLEMENTARY INFORMATION:    In
                                                  pp. 766–787.                                                         DEPARTMENT OF HEALTH AND                                                     compliance with 44 U.S.C. 3507, FDA
                                             6. O’Donoghue, A.C., H.W. Sullivan, K.J.                                  HUMAN SERVICES                                                               has submitted the following proposed
                                                  Aikin, et al. (2014). ‘‘Important Safety                                                                                                          collection of information to OMB for
                                                  Information or Important Risk                                        Food and Drug Administration                                                 review and clearance.
                                                  Information? A Question of Framing in
                                                  Prescription Drug Advertisements.’’                                  [Docket No. FDA–2014–D–1837]                                                 Transfer of a Premarket Notification
                                                  Therapeutic Innovation and Regulatory
                                                  Science, 48: pp. 305–307. doi: 10.1177/                              Agency Information Collection                                                OMB Control Number 0910-New
                                                  2168479013510306                                                     Activities; Submission for Office of                                           The draft guidance ‘‘Transfer of a
                                             7. Kahneman, D. (2011). Thinking, Fast and                                Management and Budget Review;                                                Premarket Notification (510(k))
                                                  Slow. New York, NY: Farrar, Straus, and                              Comment Request; Transfer of a                                               Clearance—Questions and Answers’’ is
                                                  Giroux.                                                              Premarket Notification
                                             8. Rothman, A.J. and P. Salovey (1997).                                                                                                                intended to provide information on how
                                                  ‘‘Shaping Perceptions To Motivate                                    AGENCY:           Food and Drug Administration,                              to notify FDA of the transfer of a 510(k)
                                                  Healthy Behavior: The Role of Message                                HHS.                                                                         clearance from one person to another,
                                                  Framing.’’ Psychological Bulletin, 121:                              ACTION:       Notice.                                                        and the procedures FDA and industry
                                                  pp. 3–19.                                                                                                                                         should use to ensure public information
                                             9. Armstrong, K., J.S. Schwartz, G. Fitzgerald,                           SUMMARY:   The Food and Drug                                                 in FDA’s databases about the current
                                                  et al. (2002). ‘‘Effect of Framing as Gain                           Administration (FDA) is announcing                                           510(k) holder for a specific device(s) is
                                                  Versus Loss on Understanding and                                     that a proposed collection of
                                                  Hypothetical Treatment Choices:                                                                                                                   accurate and up-to-date. The proposed
                                                  Survival and Mortality Curves.’’ Medical
                                                                                                                       information has been submitted to the                                        information collection seeks to provide
                                                  Decision Making, 22: pp. 76–83.                                      Office of Management and Budget                                              information to notify FDA of the transfer
                                             10. National Center for Health Statistics                                 (OMB) for review and clearance under                                         of a premarket notification (510(k))
                                                  (2016). ‘‘Health, United States, 2015:                               the Paperwork Reduction Act of 1995.                                         clearance.
                                                  With Special Feature on Racial and                                   DATES: Fax written comments on the                                             The respondents to this collection of
                                                  Ethnic Health Disparities.’’ Hyattsville,                            collection of information by April 12,                                       information are 510(k) holders and
                                                  MD.                                                                  2018.
                                             11. Brick, J.M. and D. Williams (2013).
                                                                                                                                                                                                    parties claiming to be 510(k) holders.
                                                  ‘‘Explaining Rising Nonresponse Rates in                             ADDRESSES: To ensure that comments on                                          In the Federal Register of December
                                                  Cross-Sectional Surveys.’’ The Annals of                             the information collection are received,                                     22, 2014 (79 FR 76331), FDA published
                                                  the American Academy of Political and                                OMB recommends that written                                                  a 60-day notice requesting public
                                                  Social Science, 645: pp. 36–59.                                      comments be faxed to the Office of                                           comment on the proposed collection of
                                             12. Groves, R.M. (2006). ‘‘Nonresponse Rates                              Information and Regulatory Affairs,                                          information. While FDA received
                                                  and Nonresponse Bias in Household                                                                                                                 comments on the draft guidance
                                                  Surveys.’’ Public Opinion Quarterly, 70:
                                                                                                                       OMB, Attn: FDA Desk Officer, Fax: 202–
                                                  pp. 646–675.                                                         395–7285, or emailed to oira_                                                document, none were related to the
                                             13. Betts, K.R., V. Boudewyns, K.J. Aikin, C.                             submission@omb.eop.gov. All                                                  information collection.
                                                  Squire, et al. (2017). ‘‘Serious and                                 comments should be identified with the                                         FDA estimates the burden of this
                                                  Actionable Risks, Plus Disclosure:                                   OMB control number 0910–New and                                              collection of information as follows:

                                                                                                          TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
                                                                                                                                                                       Number of                                                Average
                                                                                                                                            Number of                                            Total annual
                                                                                   Activity                                                                          responses per                                            burden per              Total hours
                                                                                                                                           respondents                                            responses
                                                                                                                                                                       respondent                                              response

                                             Voluntary reporting of transfer of 510(k) clearance on
                                               FDA’s Unified Registration and Listing System (FURLS)
                                               (outside of annual listing reporting requirement) .............                                           4,080                             1                   4,080                       0.25              1,020
                                             Submission of 510(k) transfer documentation when more
                                               than one party lists the same 510(k) ...............................                                      2,033                            1                    2,033                            4            8,132

                                                  Total ..............................................................................    ........................   ........................   ........................   ........................          9,152
amozie on DSK30RV082PROD with NOTICES




                                                1 There   are no capital costs or operating and maintenance costs associated with this collection of information.


                                               FDA estimates that 78 percent of                                        2009 through fiscal year 2014. Fiscal                                        their listings and, therefore, an
                                             510(k)s are listed outside of the annual                                  year 2008 was left out of this cohort as                                     unusually high number of listings were
                                             registration cycle based on numbers in                                    it was the first year that registrants were                                  created. An average of 5,231 510(k)s
                                             the FURLS database from fiscal year                                       required to report the 510(k) number on                                      have been listed each year since 2008.


                                        VerDate Sep<11>2014       17:47 Mar 12, 2018          Jkt 244001      PO 00000        Frm 00040        Fmt 4703       Sfmt 4703       E:\FR\FM\13MRN1.SGM                13MRN1


                                                                           Federal Register / Vol. 83, No. 49 / Tuesday, March 13, 2018 / Notices                                                  10863

                                             Because listing outside of the annual                     Dated: March 7, 2018.                               description of the oral presentation. Only one
                                             requirement is voluntary, FDA estimates                 Leslie Kux,                                           representative of an organization may be
                                             that annually 78 percent of 510(k)s will                Associate Commissioner for Policy.                    allowed to present oral comments and if
                                                                                                                                                           accepted by the committee, presentations
                                             continue to be listed outside of the                    [FR Doc. 2018–04995 Filed 3–12–18; 8:45 am]           may be limited to five minutes. Both printed
                                             annual requirement. FDA estimates that                  BILLING CODE 4164–01–P                                and electronic copies are requested for the
                                             4,080 510(k)s may be listed outside of                                                                        record. In addition, any interested person
                                             the annual registration cycle. FDA                                                                            may file written comments with the
                                             estimates that it will take approximately               DEPARTMENT OF HEALTH AND                              committee by forwarding their statement to
                                             15 minutes for each listing, for a total                HUMAN SERVICES                                        the Contact Person listed on this notice. The
                                             reporting burden of 1,020 hours.                                                                              statement should include the name, address,
                                               FDA estimates it will have 2,033                      National Institutes of Health                         telephone number and when applicable, the
                                             instances of more than one party                                                                              business or professional affiliation of the
                                             claiming to be a 510(k) holder for a                    Office of the Director, National                      interested person.
                                                                                                     Institutes of Health; Notice of Meeting                  In the interest of security, NIH has
                                             specific device as part of annual                                                                             instituted stringent procedures for entrance
                                             registration and listing. FDA reached                      Pursuant to section 10(d) of the                   onto the NIH campus. All visitor vehicles,
                                             this estimate by identifying the number                 Federal Advisory Committee Act, as                    including taxicabs, hotel, and airport shuttles
                                             of unique 510(k) device listings entered                amended, notice is hereby given of a                  will be inspected before being allowed on
                                             in FURLS between fiscal years 2009 and                  meeting of the Advisory Committee on                  campus. Visitors will be asked to show one
                                             2014 that conflict with a listing already               Research on Women’s Health.                           form of identification (for example, a
                                             entered by another party (5,304),                                                                             government-issued photo ID, driver’s license,
                                                                                                        The meeting will be open to the                    or passport) and to state the purpose of their
                                             dividing that number by the number of                   public as indicated below, with
                                             years (6), and multiplying by the                                                                             visit.
                                                                                                     attendance limited to space available.                   Information is also available on the
                                             average number of parties claiming to be                Individuals who plan to attend and                    Institute’s/Center’s home page:
                                             the 510(k) holder when there is a                       need special assistance, such as sign                 www4.od.nih.gov/orwh/, where an agenda
                                             conflict in the current FURLS database                  language interpretation or other                      and any additional information for the
                                             (2.3). The draft guidance identifies                    reasonable accommodations, should                     meeting will be posted when available.
                                             potential documentation a party could                   notify the Contact Person listed below                (Catalogue of Federal Domestic Assistance
                                             submit to FDA to establish the transfer                 in advance of the meeting.                            Program Nos. 93.14, Intramural Research
                                             of a 510(k) clearance. FDA estimates it                    A portion of the meeting will be                   Training Award; 93.22, Clinical Research
                                             will take a party approximately 4 hours                 closed to the public in accordance with               Loan Repayment Program for Individuals
                                             to locate and submit information to                                                                           from Disadvantaged Backgrounds; 93.232,
                                                                                                     the provisions set forth in sections                  Loan Repayment Program for Research
                                             establish the transfer of the 510(k)                    552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                             clearance, resulting in 8,132 burden                                                                          Generally; 93.39, Academic Research
                                                                                                     as amended. The grant applications and                Enhancement Award; 93.936, NIH Acquired
                                             hours for those 2,033 parties claiming to               the discussions could disclose                        Immunodeficiency Syndrome Research Loan
                                             be 510(k) holders. FDA reached this                     confidential trade secrets or commercial              Repayment Program; 93.187, Undergraduate
                                             estimate based on its expectation of the                property such as patentable material,                 Scholarship Program for Individuals from
                                             amount of time it will take a party to                  and personal information concerning                   Disadvantaged Backgrounds, National
                                             locate the information, copy it, and                    individuals associated with the grant                 Institutes of Health, HHS)
                                             submit a copy to FDA.                                   applications, the disclosure of which                   Dated: March 6, 2018.
                                               The burden estimate does not include
                                                                                                     would constitute a clearly unwarranted                Michelle Trout,
                                             the maintenance of records used to
                                                                                                     invasion of personal privacy.                         Program Analyst, Office of Federal Advisory
                                             document transferring a premarket
                                             notification (510(k)) clearance. Based on                  Name of Committee: Advisory Committee              Committee Policy.
                                             available information, FDA believes that                on Research on Women’s Health.                        [FR Doc. 2018–04954 Filed 3–12–18; 8:45 am]
                                                                                                        Closed: April 17, 2018, 2:30 p.m. to 4:45
                                             the maintenance of these records is a                                                                         BILLING CODE 4140–01–P
                                                                                                     p.m.
                                             usual and customary part of normal                         Agenda: To evaluate the Sex/Gender
                                             business activities. For example, in the                Administrative Supplements program
                                             ordinary course of business, supporting                 proposed for ORWH’s Strategic Plan.                   DEPARTMENT OF HEALTH AND
                                             documents should be kept to verify                         Open: April 18, 2018, 9:00 a.m. to 1:30            HUMAN SERVICES
                                             asset information for calculating the                   p.m.
                                             annual depreciation or calculating gain                    Agenda: Opening Remarks, Director’s                National Institutes of Health
                                             or loss on sale of an asset on a                        Report, NIH Legislative Update, Strategic
                                                                                                     Plan Update, and Scientific Presentations.            Eunice Kennedy Shriver National
                                             businesses’ tax return. Therefore, this                                                                       Institute of Child Health and Human
                                                                                                        Place: National Institutes of Health,
                                             recordkeeping requirement creates no                    Building 31, 6th Floor, Conference Room 10,           Development; Notice of Closed
                                             additional paperwork burden.                            31 Center Drive, Bethesda, MD 20892.                  Meetings
                                               The draft guidance also refers to                        Contact Person: Elizabeth Spencer, R.N.,
                                             previously approved collections of                      Deputy Director, Office of Research on                  Pursuant to section 10(d) of the
                                             information found in FDA regulations.                   Women’s Health, Executive Secretary,                  Federal Advisory Committee Act, as
                                             The collections of information in 21                    ACRWH, National Institutes of Health, 6707            amended, notice is hereby given of the
                                             CFR part 807 (registration and listing)                 Democracy Blvd., Room 7W444, Bethesda,                following meetings.
                                             are approved under OMB control                          MD 20817, 301–402–1770 elizabeth.spencer@               The meetings will be closed to the
                                             number 0910–0625; the collections of                    nih.gov.                                              public in accordance with the
amozie on DSK30RV082PROD with NOTICES




                                             information in 21 CFR part 807 subpart                     Any member of the public interested in             provisions set forth in sections
                                             E (premarket notification submission)                   presenting oral comments to the committee             552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
                                                                                                     may notify the Contact Person listed on this
                                             have been approved under OMB control                    notice at least 10 days in advance of the
                                                                                                                                                           as amended. The grant applications and
                                             number 0910–0120, and collections of                    meeting. Interested individuals and                   the discussions could disclose
                                             information in 42 CFR 493.17 have been                  representatives of organizations may submit           confidential trade secrets or commercial
                                             approved under OMB control number                       a letter of intent, a brief description of the        property such as patentable material,
                                             0910–0607.                                              organization represented, and a short                 and personal information concerning


                                        VerDate Sep<11>2014   17:47 Mar 12, 2018   Jkt 244001   PO 00000   Frm 00041   Fmt 4703   Sfmt 4703   E:\FR\FM\13MRN1.SGM   13MRN1



Document Created: 2018-03-13 01:56:59
Document Modified: 2018-03-13 01:56:59
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesFax written comments on the collection of information by April 12, 2018.
ContactAmber Sanford, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-8867, [email protected]
FR Citation83 FR 10862 

2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR